Q1 FY27 results - Symbiotec's first post-IPO filing

Revenue DeclineEbitda Margin CompressionResults View source PDF Explain this filing

SYMBIOTEC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.6%Reaction day

₹1162.45

prior close

₹1099.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-4.0% vs market

On the reaction day the stock moved 4.0 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.9

10m

+3.0

15m

+6.1

30m

+5.9

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-3.6+0.4-4.0

Next day

-8.7+1.7-10.5

-12.4+0.2-12.6

-13.4+0.5-13.9

-9.2-1.1-8.1

-1.7-0.1-1.6

+3.0-1.6+4.6

15d

+6.9-1.4+8.3

+2.8-7.4+10.2

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Symbiotec Q1 FY27 consolidated revenue Rs 218.15 crore, up 7.4% YoY but down 11% QoQ. Consolidated net profit dropped to Rs 14.05 crore from Rs 29.92 crore YoY. Standalone net profit grew to Rs 47.01 crore from Rs 44.50 crore YoY. First quarterly result since NSE and BSE listing on September 1, 2026, following a Rs 1,757 crore IPO. Auditor SRBC gave an unmodified review. No exceptional items in the quarter.

Likely market impact

First post-IPO results show mixed picture. Consolidated profits nearly halved YoY though standalone grew. Watch margin trends and subsidiary losses.